regulatory compliance
Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco
May 05 by Pharma IQ News(San Francisco, CA.) IQPC’s 19th Software Design for Medical Devices Summit is pleased to announce the chairman of the Summit Mr. Phani Bidarahalli, GM & Head of Healthcare Engineeri...
Don’t Get Lost in Translation – Reflections on Pharmaceutical Labelling
May 07 by Helen WinsorMark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive intervi...
Immunogenicity: Unwanted!
April 13 by Pharma IQThe journey from drug design to market can be a long and arduous one, with several obstacles to overcome, and immunogenicity is one which has derailed many applications. Unwanted immunogenicity c...
Compliance Packaging, Walmart and Improving Patient Outcomes
April 03 by Andrea CharlesAccording to Freedonia's US Pharmaceutical Packaging Market report, demand for pharmaceutical packaging is projected to grow in the US to $18.4 billion by 2014. In this interview Charles Aub...
Can You Stay Ahead of the Pack in Pharmaceutical Packaging and Labelling?
March 17 by Pharma IQAs the nature of the pharmaceutical packaging and labelling industry continues to evolve, organisations are faced with many challenges, including keeping up with regulatory requirements and ensuring t...
FDA Compliance: Minimising Risk
November 18 by Pharma IQCompliance with Food and Drugs Administration (FDA) guidelines is essential for all working within the pharmaceutical industry, from researchers working on clinical trials to those marketing the drugs...
Labelling Compliance for Medical Devices: Wanted Global Harmonisation!
November 02 by Pharma IQPeter Schroeer, Director Europe, Quality Systems & Regulatory Affairs at Johnson & Johnson, speaks to Andrea Charles from Pharma IQ, about the current compliance challenges the...
Challenges and Changes in Bioequivalence Studies
August 15 by Pharma IQHelmut Schutz, CEO of BEBAC, joins Helen Winsor from Pharma IQ, to talk about the challenge of sample sizes in bioequivalence studies. The interview explores the idea of literature data versus pilot s...
Getting to Grips with Stability Testing and Regulatory Compliance
March 28 by Helen WinsorWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Find out more about the challenges in pre-and post-release stability te...
FDA Concerned About Lack of PI Oversight in Early Phase Clinical Trials
March 28 by Andrea CharlesIn part one of this interview Dan Sfera from The Clinical Trials Guru, speaks to Andrea Charles from Pharma IQ, about the big trends making an impact in clinical research, the FDA'...